Today at Ms. | December 20, 2021


With Today at Ms. —a daily newsletter from the team here at Ms. magazine—our top stories are delivered straight to your inbox every afternoon, so you’ll be informed and ready to fight back.


Build Back Better Is in Peril. Low-income Families Can’t Afford To Lose It [[link removed]]

BY KATIE FLEISCHER | As families hope Democratic leadership will find a different path to pass Build Back Better policies like childcare or paid leave, another revolutionary policy is just beginning to enter mainstream awareness: guaranteed income.
Guaranteed income involves regular payments directed to specific marginalized groups, as a way to address economic inequities caused by systemic racism and sexism. Economic justice organizations like the Magnolia Mother’s Trust argue that a federal guaranteed income program would not just help low-income families pay their bills, but also reduce financial stress and set their families up for long-term success.
(Click here to read more) [[link removed]]

Dear Joe Manchin: Think Build Back Better Is Expensive? Wait Till You Hear the U.S. Defense Budget. [[link removed]]
BY MARTHA BURK | The main objection to President Biden’s Build Back Better plan by Republicans and so-called “moderate” Democrats is the price tag—$1.75 trillion over 10 years. If that sounds like a lot of money, it is—until you compare it to the boys and their toys.
We don’t need a rocket scientist to tell us why women’s jobs aren’t recovering: a lack of childcare and universal pre-kindergarten, a lack of paid family leave. The Build Back Better Act would go a long way toward fixing that.

The FDA Is Moving To Align With Science and Expand Abortion Access [[link removed]]
BY SARAH RAIFMAN | Up until Thursday, FDA regulations on the abortion pill mifepristone consisted of three components:
1. providers must complete a self-certification process with the drug’s distributor to provide mifepristone;
2. patients must sign a special patient-agreement form; and
3. the pills must be dispensed in a clinic, medical office or hospital.
The FDA has permanently removed the third requirement and will allow certified pharmacies to dispense the pills. While the decision is good news, it does not go far enough to align with the evidence. Still, the removal of the in-person dispensing requirement for mifepristone is an essential first step.

[[link removed]]
Tune in for a new episode of Ms. magazine's podcast, On the Issues with Michele Goodwin on Apple Podcasts [[link removed]] + Spotify [[link removed]] .
On December 1, the Supreme Court held oral arguments in Dobbs v. Jackson Women’s Health Organization —a case that some believe could overturn Roe v. Wade . The case involves a Mississippi abortion provision, banning most abortions after 15 weeks, with no exceptions for rape or incest. So, what’s at stake in Dobbs—both in terms of abortion rights, and in terms of the Supreme Court’s legitimacy?
We hope you'll listen, subscribe, rate and review today!


[link removed] [[link removed]]
[link removed] [[link removed]]



Ms. Magazine
1600 Wilson Boulevard
Suite 801
Arlington, VA 22209
United States

If you believe you received this message in error or wish to no longer receive email from us, please unsubscribe: [link removed] .